Subscribe to RSS

DOI: 10.1590/0004-282X20160037
Vestibular migraine: diagnosis challenges and need for targeted treatment
Migrânea vestibular: desafios diagnósticos e a necessidade de tratamentos específicos
ABSTRACT
Approximately 1% of the general population suffers from vestibular migraine. Despite the recently published diagnostic criteria, it is still underdiagnosed condition. The exact neural mechanisms of vestibular migraine are still unclear, but the variability of symptoms and clinical findings both during and between attacks suggests an important interaction between trigeminal and vestibular systems. Vestibular migraine often begins several years after typical migraine and has a variable clinical presentation. In vestibular migraine patients, the neurological and neurotological examination is mostly normal and the diagnosis will be based in the patient clinical history. Treatment trials that specialize on vestibular migraine are scarce and therapeutic recommendations are based on migraine guidelines. Controlled studies on the efficacy of pharmacologic interventions in the treatment of vestibular migraine should be performed.
RESUMO
Cerca de 1% da população apresentam o diagnóstico de migrânea vestibular. Apesar dos critérios diagnósticos terem sido publicados recentemente, ainda é uma condição subdiagnosticada. Os mecanismos neurais exatos da migrânea vestibular ainda não estão claros, mas a variabilidade dos sintomas e achados clínicos durante e entre os ataques sugere uma interação importante entre os sistemas trigeminal e vestibular. A migrânea vestibular geralmente começa alguns anos após a migrânea típica e tem apresentação clínica variável. Em pacientes com migrânea vestibular, o exame neurológico e otoneurológico são geralmente normais e o diagnóstico é baseado na história clínica do paciente. Estudos sobre tratamento da migrânea vestibular são escassos e recomendações terapêuticas são baseadas em diretrizes do tratamento da migrânea. Estudos controlados sobre a eficácia das intervenções farmacológicas para o tratamento da migrânea vestibular devem ser realizados.
Publication History
Received: 29 January 2015
Accepted: 13 January 2016
Article published online:
06 September 2023
© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Yardley L, Owen N, Nazareth I, Luxon L. Prevalence and presentation of dizziness in a general practice community sample of working age people. Br J Gen Pract. 1998;48(429):1131-5.
- 2 Neuhauser H, Leopold M, Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436-41. doi:10.1212/WNL.56.4.436
- 3 Lee H, Sohn SI, Jung DK, Cho YW, Lim JG, Yi SD et al. Migraine and isolated recurrent vertigo of unknown cause. Neurol Res. 2002;24(7):663-5. doi:10.1179/016164102101200726
- 4 Cha YH, Lee H, Santell LS, Baloh RW. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia. 2009;29(5):550-5. doi:10.1111/j.1468-2982.2008.01770.x
- 5 Cal R, Bahmad F Jr. Migraine associated with auditory-vestibular dysfunction. Braz J Otorhinolaryngol. 2008;74(4):606-12. doi: 10.1016/S1808-8694(15)30611-X
- 6 Liveing E. On megrim, sick-headache, and some allied disorders. London, UK: Churchill, 1873.
- 7 Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107(4):1123-42. doi:10.1093/brain/107.4.1123
- 8 Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol. 2003;16(1):5-13. doi:10.1097/00019052-200302000-00002
- 9 Neuhauser, H.K., Lempert, T. Vertigo: epidemiologic aspects. Semin Neurol. 2009;9(5):473-81. doi:10.1055/s-0029-1241043
- 10 Brandt T, Strupp M. Migraine and vertigo: classification, clinical features, and special treatment considerations. Headache Currents. 2006;3(1):12-9. doi:10.1111/j.1743-5013.2006.00027.x
- 11 Geser R, Straumann D. Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol. 2012;3:169. doi:10.3389/fneur.2012.00169
- 12 Neuhauser HK, Radtke A, Brevern M, Feldmann M, Lezius F, Ziese T et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67:1028. doi:10.1212/01.wnl.0000237539.09942.06
- 13 Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia. 2004;24(2):83-91. doi:10.1111/j.1468-2982.2004.00662.x
- 14 Hsu LC, Wang SJ, Fuh JL. Prevalence and impact of migrainous vertigo in mid-life women: a community-based study. Cephalalgia. 2011;31(1):77-83. doi:10.1177/0333102410373152
- 15 Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883-92. doi:10.1007/s004150050478
- 16 Murdin L, Davies RA, Bronstein AM. Vertigo as a migraine trigger. Neurology. 2009;73(8):638-42. doi:10.1212/WNL.0b013e3181b38a04
- 17 Abu-Arafeh I, Russell G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study. Cephalalgia. 1995;15(1):22-5. doi:10.1046/j.1468-2982.1995.1501022.x
- 18 Sargent, EW. The challenge of vestibular migraine. Curr Opin Otolaryngol Head Neck Surg. 2013;21(5):473-9. doi:10.1097/MOO.0b013e3283648682
- 19 Balaban CD. Migraine, vertigo and migrainous vertigo: links between vestibular and pain mechanisms. J Vestib Res. 2011;21(6):315-21. doi:10.3233/VES-2011-0428
- 20 Schuerger RJ, Balaban CD. Organization of the coeruleo-vestibular pathway in rats, rabbits, and monkeys. Brain Res Brain Res Rev. 1999;30(2):189-217. doi:10.1016/S0165-0173(99)00015-6
- 21 Halberstadt AL, Balaban CD. Organization of projections from the raphe nuclei to the vestibular nuclei in rats. Neuroscience. 2003;120(2):573-94. doi:10.1016/S0306-4522(02)00952-1
- 22 Marano E, Marcelli V, Di Stasio E, Bonuso S, Vacca G, Manganelli F et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache. 2005;45(4):325-31. doi:10.1111/j.1526-4610.2005.05069.x
- 23 Shin JH, Kim YK, Kim HJ, Kim JS. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58-67. doi:10.1177/0333102413498940
- 24 Russo A, Marcelli V, Esposito F, Corvino V, Marcuccio L, Giannone A et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120-6. doi:10.1212/WNL.20160037201600370496
- 25 Stolte B, Holle D, Naegel S, Diener HC, Obermann M. Vestibular migraine. Cephalalgia. 2014;35(3):262-70. doi:10.1177/0333102414535113
- 26 Bahmad F Jr, DePalma SR, Merchant SN, Bezerra RL, Oliveira CA, Seidman CE et al. Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann Otol Rhinol Laryngol. 2009;118(9):670-6. doi:10.1177/000348940911800912
- 27 Lee H, Jen JC, Wang H, Chen Z, Mamsa H, Sabatti C et al. A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet. 2006;15(2):251-8. doi:10.1093/hmg/ddi441
- 28 International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. doi:10.1177/0333102413485658
- 29 Furman JM, Marcus DA, Balaban CD. Vestibular igraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706-15. doi:10.1016/S1474-4422(13)70107-8
- 30 Cohen JM, Bigal ME, Newman LC. Migraine and vestibular symptoms: identifying clinical features that predict “vestibular migraine”. Headache. 2011;51(9):1393-7. doi:10.1111/j.1526-4610.2011.01934.x
- 31 Strupp M, Versino M, Brandt T. Vestibular migraine. Handb Clin Neurol. 2010;97:755-71. doi:10.1016/S0072-9752(10)97062-0
- 32 Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache. 1992;32(6):300-4. doi:10.1111/j.1526-4610.1992.hed3206300.x
- 33 Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope. 1998;108(suppl S85):1-28. doi:10.1111/j.1526-4610.1992.hed3206300.x
- 34 Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol. 2002;23(3):364-71. doi:10.1097/00129492-200205000-00024
- 35 Lempert T, Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine. J Neurol. 2009;256(3):333-8. doi:10.1007/s00415-009-0149-2
- 36 Radtke A, Brevern M, Neuhauser H, Hottenrott T, Lempert T. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607-14. doi:10.1212/WNL.0b013e31826e264f
- 37 Lempert, T. Vestibular migraine. Semin Neurol. 2013;33(3):212-8. doi:10.1055/s-0033-1354596
- 38 Vitkovic J, Paine M, Rance G. Neuro-otological findings in patients with migraine- and nonmigraine-related dizziness. Audiol Neurootol. 2008;13(2):113-22. doi:10.1159/000111783
- 39 Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(2):365-74. doi:10.1093/brain/awh351
- 40 Ménière P. Pathologie auriculaire: memoires sur une lésion de l’oreille interne donnant lieu à des symptoms de congestion cérébrale apoplectiforme. Gaz Med Paris. 1861;16:597-601.
- 41 Parker W. Menière’s disease. Etiologic considerations. Arch Otolaryngol Head Neck Surg. 1995;121(4):377-82. doi:10.1001/archotol.1995.01890040005001
- 42 Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. et al. Migraine and Ménière’s disease: is there a link? Neurology. 2002;59(11):1700-4. doi:10.1212/01.WNL.0000036903.22461.39
- 43 Griev, SM, Obholzer R, Malitz N, Gibson WP, Parker GD. Imaging of endolymphatic hydrops in Meniere’s disease at 1.5 T using phase-sensitive inversion recovery: (1) demonstration of feasibility and (2) overcoming the limitations of variable gadolinium absorption. Eur J Radiol. 81(2):331-8. doi:10.1016/j.ejrad.2011.01.073
- 44 Gürkov R, Kantner C, Strupp M, Flatz W, Krause E, Ertl Wagner B. Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol. 2014;271(10):2661-7. doi:10.1007/s00405-013-2751-2
- 45 Nakada T, Yoshida T, Suga K, Kato M, Otake H, Kato K et al. Endolymphatic space size in patients with vestibular migraine and Ménière’s disease. J Neurol. 2014;261(11):2079-84. doi:10.1007/s00415-014-7458-9
- 46 Lee SH, Kim JS. Benign paroxysmal positional vertigo. J Clin Neurol. 2010;6(2):51-63. doi:10.3988/jcn.2010.6.2.51
- 47 Brevern M, Radtke A, Clarke AH and Lempert T. Migrainous vertigo presenting as episodic positional vertigo. Neurology. 2004;62(3):469-72. doi:10.1212/01.WNL.0000106949.55346.CD
- 48 Baloh RW. Vertebrobasilar insufficiency and stroke. Otolaryngol Head Neck Surg. 1995;112(1):114-7. doi:10.1016/S0194-5998(95)70309-8
- 49 Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782-86. doi:10.1097/01.mlg.0000231302.77922.c5
- 50 Neuhauser H, Radtke A, Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882-3. doi:10.1212/01.WNL.0000049476.40047.A3
- 51 Lepcha A, Amalanathan S, Augustine AM, Tyagi AK, Balraj A. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931-6. doi:10.1007/s00405-013-2786-4
- 52 Taghdiri F, Togha M, Razeghi Jahromi S, Refaeian F. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. SpringerPlus. 2014;3(1):231. doi:10.1186/2193-1801-3-231
- 53 Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an obsevational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;(2):103-8.
- 54 Baier B, Winkenwerder E, Dieterich M. “Vestibular migraine”: effects of prophylactic therapy with various drugs: a retrospective study. J Neurol. 2009;256(3):436-42. doi:10.1007/s00415-009-0111-3
- 55 Obermann M, Strupp M. Current treatment options in vestibular migraine. Front Neurol. 2014;5:257. doi:10.3389/fneur.2014.00257
- 56 Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol. 2012;33(1):121-7. doi:10.1016/j.amjoto.2011.04.010
- 57 Vitkovic J, Winoto A, Rance G, Dowell R, Paine M. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039-48. doi:10.1007/s00415-013-7116-7
- 58 Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy for migraine related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope. 2000;110(9):1528-34. doi:10.1097/00005537-200009000-00022
- 59 Wrisley DM, Whitney SL, Furman JM. Vestibular rehabilitation outcomes in patients with a history of migraine. Otol Neurotol. 2002;23(4):483-7. doi:10.1097/00129492-200207000-00016